This is a $10,229.60 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Deafness and Other Communication Disorders to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for Exome Variant Analyses Software and has a completion date of May 1, 2025. No set-aside designation was used. Qiagen is an experienced federal contractor, having provided a range of sample and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC, a division of Qiagen N.V. The contract, valued at $32,995.00, is to provide Ingenuity Variant Analysis software and services in support of the agency's biomedical research programs. Qiagen, a provider of sample and assay technologies, has a history of providing products and...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
This is a $22,536 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract is for IPA (Ingenuity Pathway Analysis) software licenses and LCL (local community) group licenses. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research, and has held numerous federal...
This $16,000.00 firm-fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian federal agency, to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is for "INGENUITY VARIANT ANALYSIS" and does not have a set-aside designation. Qiagen is an experienced federal contractor that has provided a range of molecular diagnostics products, reagents, equipment, and related services to...
This is a $16,800 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for NIDDK to acquire 1,000 QCII Translational biospecimen samples. Qiagen provides a wide range of molecular diagnostics products, services, and instrumentation to federal agencies, including the Department of Health and Human Services, Department of Defense,...
This is a $24,917.48 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for RNA isolation services. The contract is not set aside and has an ultimate completion date of June 11, 2025. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has provided various products and services...
This is a $15,641 firm fixed-price purchase order contract awarded by the National Eye Institute (NEI), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for a software license and does not have a set-aside designation. Qiagen is a well-established federal contractor, holding multiple indefinite delivery vehicles with various government agencies to provide specialized scientific...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The $9,445.00 firm fixed-price contract does not have a set-aside designation. The contract supports NIAID's biomedical research, public health, and healthcare programs through the provision of Qiagen's sample and assay technologies, including...